Winston Pharmaceuticals, Inc. (WPHM): Glenn L Halpryn, Chairman and CEO -Mi...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	46
Posts	2829
Boards Moderated	1
Alias Born	07/20/2006

atout

Re: None

Saturday, 02/24/2007 2:06:26 PM

Saturday, February 24, 2007 2:06:26 PM

Glenn L Halpryn, Chairman and CEO

-Miami investor
-Chairman and CEO of Orthodontix, Inc. (OTIX), (shell/merger with Protalix Ltd., an Israeli biotech company.)
-Part of an investor group that, together with Dr. Phillip Frost, purchased a 14% stake in Protalix.

Glenn L. Halpryn. Mr. Halpryn has been Chairman of the Board and Chief
Executive Officer of Orthodontix, Inc., a public company, since April 2001.
Mr. Halpryn is also Chief Executive Officer and a director of Transworld
Investment Corporation ("TIC"), serving in such capacity since June 2001.
Since 2000, Mr. Halpryn has been an investor and the managing member of
investor groups that were joint venture partners in 26 land acquisition and
development projects with one of the largest home builders in the country.
From 1984 to June 2001, Mr. Halpryn served as Vice President/Treasurer of TIC.
From 1999, Mr. Halpryn also served as Vice President of Ivenco, Inc.
("Ivenco") until Ivenco's merger into TIC in June 2001. In addition, since
1984, Mr. Halpryn has been engaged in real estate investment and development
activities. From April 1988 through June 1998, Mr. Halpryn was Vice Chairman
of Central Bank, a Florida state-chartered bank. Since June 1987, Mr.
Halpryn has been the President of and beneficial holder of stock of United
Security Corporation ("United Security"), a broker-dealer registered with the
NASD. From June 1992 through May 1994, Mr. Halpryn served as the Vice
President, Secretary-Treasurer of Frost Hanna Halpryn Capital Group, Inc., a
"blank check" company whose business combination was effected in May 1994
with Sterling Healthcare Group, Inc. From June 1995 through October 1996, Mr.
Halpryn served as a member of the Board of Directors of Sterling Healthcare
Group, Inc. Since October 2002, Mr. Halpryn has been a director of Ivax
Diagnostics, Inc., a publicly held corporation, and is a member of its audit
committee and chairman of its compensation committee.